Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate: Results at 84 Weeks from the Select-Monotherapy Study

Results

Naziv:	Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate: Results at 84 Weeks from the Select-Monotherapy Study
Autori:	Smolen, Josef S; Emery, Paul; Rigby, William; Tanaka, Yoshiya; Vargas, Ignacio J; Damjanov, Nemanja S; Jain, Manish; Song, Yanna; Khan, Nasser; Enejosa, Jeffrey; Cohen, Stanley B;
Godina:	2020
Publikacija:	ANNALS OF THE RHEUMATIC DISEASES
ISSN:	0003-4967 Annals of the Rheumatic Diseases Pretraži identifikator
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 79 br. Suppl 1 str. 327-332
DOI:	10.1136/annrheumdis-2020-eular.961
WoS-ID:	000555905001057
URI:	https://enauka.gov.rs/handle/123456789/797162
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

1
OpenCitations

3
WEB OF SCIENCE^TM

Altmetric

Dimensions

Unpaywall

Google Scholar^TM